Clinical and molecular aspects of a pediatric metachronous adrenocortical tumor;Aspectos clínicos e moleculares de tumor adrenocortical metacrônico pediátrico

Arquivos Brasileiros de Endocrinologia e Metabologia

Volumn 55, Issue 1, 2011, Pages 72-77

  de Oliveira Lima, Lorena ^a   Lerario, Antonio Marcondes ^a   Alencar, Guilherme Asmar ^a   Brito, Luciana Pinto ^a   Almeida, Madson Queiroz ^a   Domenice, Sorahia ^a   Latronico, Ana Claudia ^a   Mendonca, Berenice Bilharinho ^a   Fragoso, Maria Candida Barrison Villares ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79954561209     PISSN: 00042730     EISSN: 16779487     Source Type: Journal    
DOI: 10.1590/S0004-27302011000100010     Document Type: Article

References (19)

1. Ribeiro RC, Sandrini F, Figueiredo B, Zambetti GP, Michalkiewicz E, Lafferty AR, et al. An inherited p53 mutation that contributes in a tissue-specific manner to pediatric adrenal cortical carcinoma. Proc Natl Acad Sci. 2001;98(16):9330-9335.
2. Latronico AC, Pinto EM, Domenice S, Fragoso MCBV, Martin RM, Zerbini MC, et al. An inherited mutation outside the highly conserved DNA-binding domain of the p53 tumor supressor protein in children and adults with sporadic adrenocortical tumors. J Clin Endocrinol Metab. 2001;86(10):4970-4973.
3. Almeida MQ, Latronico AC. The molecular pathogenesis of childhood adrenocortical tumors. Horm Metab Res. 2007;39:461-466.
4. Wieneke JA, Thompson LDR, Heffess CS. Adrenal cortical neoplasms in the pediatric population: a clinicopathologic and immunophenotypic analysis of 83 patients. Am J Surg Pathol. 2003;27(7):867-881.
5. Latronico AC, Chrousos GP. Extensive personal experience: adrenocortical tumors. J Clin Endocrinol Metabol. 1997;82(5):1317-1324.
6. Barlaskar FM, Hammer GD. The molecular genetics of adrenocortical carcinoma. Rev Endocr Metab Disord. 2007;8:343-348.
7. Bernard MH, Sidhu S, Berger N, Peix JL, Marsh DJ, Robinson BG, et al. A case report in favor of a multistep adrenocortical tumorigenesis. J Clin Endocrinol Metabol. 2003;88(3):998-1001.
8. Augbert S, Wacrenier A, Leroy X, Devos P, Carnaille B, Proye C, et al. Weiss system revisited: a clinicopathologic and immunohistochemical study of 49 adrenocortical tumors. Ann J Surg Pathol. 2002;26:1612-1619.
9. Sullivan M, Boileau M, Hodges CV. Adrenal cortical carcinoma. J Urol. 1978;120:660-665.
10. Almeida MQ, Fragoso MCBV, Lofti CFP, Santos MG, Nishi MY, Costa MHS, et al. Expression of insulin-like growth factor-II and its receptor pediatric and adult adrenocortical tumors. J Clin Endocrinol Metabol. 2008;93(9):3524-3531.
11. Brito LP, Lerario AM, Bronstein MD, Soares IC, Medonça BB, Fragoso MCBV. Influence of the fibroblast growth factor receptor 4 expression and the G388R polymorphism on cushing disease outcome. J Clin Endocrinol Metabol. 2010;95(10):E271-279.
12. Kikuchi A. Tumor formation by genetic mutations in the components of the wnt signaling pathway. Cancer Sci. 2003;94(3):225-229.
13. Libè R, Groussin L, Tissier F, Elie C, René-Corail F, Fratticci A, et al. Somatic TP53 mutations are relatively rare among adrenocortical cancers with the frequent 17p13 loss of heterozygosity. Clin Cancer Res. 2007;13(3):844-850.
14. Mendonca BB, Lucon AM, Menezes CAV, Saldanha LB, Latronico AC, Zerbini C, et al. Clinical, hormonal and pathological findings in a comparative study of adrenocortical neoplasms in childhood and adulthood. J Urol. 1995;154:2004-2009.
15. Barlaskar FM, Spalding AC, Heaton JH, Kuick R, Kim AC, Thomas DG, et al. Preclinical targeting of the type I insulin-like growth factor receptor in adrenocortical carcinoma. J Clin Endocrinol Metabol. 2009;94(1):204-212.
16. Tissier F, Cavard C, Groussin L, Perlemoine K, Fumey G, Hagneré AM, et al. Mutations of beta-catenin in adrenocortical tumors: activation of the Wnt signaling pathway is a frequent event in both benign and malignant adrenocortical tumors. Cancer Res. 2005;65(17):7622-7627.
17. Pusantisampan T, Sangkhathat S, Kanngurn S, Kayasut K, Jaruratanasirikul S, Chotsampancharoan T, et al. Cushing's syndrome in an infant secondary to malignant adrenocortical tumors with somatic mutation of beta-catenin. Pediatri Dev Pathol. 2009;13(3):238-242.
18. Ragazzon B, Libé R, Gaujoux S, Assié G, Fratticci A, Launay P, et al. Transcriptome analysis reveals that p53 and β-catenin alterations occur in a group of agressive adrenocortical cancers. Cancer Res. 2010;70(21):8276-8281.
19. West AN, Neale GA, Pounds S, Figueredo BC, Galindo CR, Pianovski MAD, et al. Gene expresion profiling of childhood adrenocortical tumors. Cancer Res. 2007;67(2):600-608.